ABSTRACT OBJECTIVES This study classified and quantified the variation in fractional flow reserve (FFR) due to fluctuations in systemic and coronary hemodynamics during intravenous adenosine infusion.
D
uring the past 20 years, fractional flow reserve (FFR) has evolved from its first animal model and theoretical introduction (1) to an everyday clinical tool to guide coronary revascularization. As a result of 3 major randomized controlled trials (2-4) and a host of observational studies (5) , both European (6) and American (7) The FAME trial used only IV adenosine (3) due to its reliability and ease of use. An opinion document on FFR for clinical trials specifically recommended IV adenosine over alternative agents such as intracoronary adenosine, papaverine, and nitroprusside (10) .
However, some investigators have recently questioned the validity of FFR measurements made during IV adenosine infusion (11, 12) . Specifically, some investigators proposed that only the FFR measured during "stable hyperemia" should be used to guide treatment, even if lower values had been observed (11) . Other investigators noted common FFR instability during IV adenosine infusion, but still recommended always using the lowest observed value (12) . 
METHODS
The VERIFY study has already been published (13) .
We sought no further ethics board review for the current analysis, because each patient provided written informed consent for VERIFY, and the pres- STATISTICAL METHODS. Statistical analyses were performed in R version 3.1.0 (R Foundation for statistical tests as detailed in the Online Appendix. All physiological data in this paper comes from our "smart minimum" algorithm except for a few human core laboratory and pressure recording system results that we explicitly identify as such in the text and in Table 1 .
RESULTS
The VERIFY study enrolled 206 patients (13) . Already Almost 25 years ago, IV adenosine infusion for hyperemia was introduced by comparison to papaverine and was evaluated using an intracoronary 3-F Doppler catheter (9) . Those authors also observed flow variations consistent with the "humped" response in our Johnson et al.
with a cycle length of about 30 seconds.when the coronary infusion rate was increased, hyperemia became sustained at the maximal level." Indeed, the case shown in their Figure 5 displays a "humped" response in flow levels, albeit at lower IV infusion rates than in our VERIFY reanalysis, but with similar periodicity. Their Table 4 suggest residual effects or a "priming" from IV adenosine even after a 2-min rest period.
Recent work proposed 7 patterns of response to IV adenosine infusion, but with an emphasis on Pa and Pd separately and without repeated, paired tracings for the same lesion (11) . However, as clarified in our Table 1 demonstrates that waiting 1 or even 2 min in hopes of achieving a "stable" period performs worse than always selecting the "smart minimum" FFR. Figure 6 make it unlikely that any "1 size fits all" solution exists for timing.
Indeed, our results in
Other recent work proposed 3 patterns of response to IV adenosine infusion, but again with an emphasis on Pa and Pd separately and without repeated, paired tracings for the same lesion (12) . Although noting similar remarks as we previously mentioned regarding paired measurements and highly repeatable "smart minimum" FFR values, we do agree with these authors that FFR pullback curves could be affected by the "humped" response pattern that occurs in roughly 40% of cases. We suggest 3 solutions: rapid pullback during the nadir phase, increased IV adenosine rate that might convert to a "classic" pattern, or serial stationary measurements along the artery of sufficient duration to obtain a "smart minimum" FFR. Our study used test/retest repeatability and agreement with human physiology core laboratories as its benchmarks. We, therefore, cannot comment on its effect on clinical events, although repeatability is generally considered an advantage in patient management guided by threshold criteria. 
